(Press-News.org) MAYWOOD, Il. -- Lower-income cancer patients are less likely to participate in cancer clinical trials, according to a study co-authored by Loyola University Medical Center oncologist Kathy Albain, MD, FACP.
Patients with incomes of less than $50,000 per year were 27 percent less likely than higher-income patients to participate in clinical trials, and those with incomes less than $20,000 were 44 percent less likely to participate.
Fifty-three percent of patients with incomes less than $20,000 per year expressed concerns about their costs of participating in clinical trials. By comparison, only 24 percent of patients earning more than $100,000 per year expressed concerns over cost.
Results were presented during the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
"We must be more vigilant in educating our lower-income patients about the value of participating in clinical trials," Albain said. "We also need to do a better job addressing misperceptions they may have about the costs of participating in clinical trials, and present all options available to them for reimbursement."
Albain chaired the committee that developed and designed the study. The study was a collaboration between SWOG (formerly known as the Southwest Oncology Group) and NexCura®. SWOG is a clinical trials network supported largely by the National Cancer Institute. NexCura, until its recent sale, had run an online treatment decision tool that many cancer advocacy organizations made available to patients.
Researchers did an online survey of 5,499 patients who were newly diagnosed with breast, prostate, lung or colorectal cancers. Overall, 9 percent of these patients participated in clinical trials. Income was the only socioeconomic or demographic factor that was significantly associated with participation in clinical trials.
Clinical trials give cancer patients access to new drugs, new treatment approaches and other investigational treatments before they are widely available -- while ensuring patients receive, at the minimum, the best standard of care. Patients also receive care at leading health care sites.
The National Cancer Institute says that costs for patients who participate in clinical trials are not appreciably higher than costs for patients who do not participate. Nevertheless, the study found that cost still was a significant concern among lower-income patients. Researchers said lower-income patients may be more sensitive to direct costs, such as co-pays and co-insurance, and indirect costs, such as time off from work for extra clinic visits.
Albain said it is critically important that all segments of society receive the benefits of clinical trials. Moreover, including all segments of the population is necessary to ensure the validity of the findings. "If a whole segment is missing or is under represented in a clinical trial, we won't know whether the findings will hold up for that segment," she said
###Albain is a professor in the Division of Hematology/Oncology in the Department of Medicine of Loyola University Chicago Stritch School of Medicine. Co-authors are Joseph Unger (first author), Carol Moinpour, Judy Petersen and John Crowley of the SWOG Statistical Center, Fred Hutchinson Cancer Research Center; Dawn Hershman of Columbia University Medical Center; and Kendra Burg of NexCura.
Lower income patients less likely to participate in cancer clinical trials
2012-06-05
ELSE PRESS RELEASES FROM THIS DATE:
New breast cancer drug halts tumor growth better than standard therapy
2012-06-05
DURHAM, N.C. – A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute.
Participants with invasive breast cancer who took the investigational drug, called trastuzumab emtansine, or T-DM1, also had fewer and less harsh side effects than study participants who received a standard treatment.
The ...
'Most comprehensive' genetic analysis of maize plant will help raise yields, expand its range
2012-06-05
Cold Spring Harbor, NY and Washington, DC – An international research team involving 17 institutions including Cold Spring Harbor Laboratory has published the most comprehensive analysis to date of the maize genome. It is an achievement that substantially increases scientists' understanding of differences across related but different species of the plant, which most North Americans call corn, as well as the nature of differences found within individual maize species.
The research is expected to speed development of improved varieties of corn, which is one of the ...
New hope for migraine sufferers
2012-06-05
New hope has arrived for migraine sufferers following a Griffith University study with the people of Norfolk Island.
Led by Professor Lyn Griffiths from the University's Griffith Health Institute,
the team has identified a new region on the X chromosome as playing a role in migraine.
The research provides compelling evidence for a new migraine susceptibility gene involved in migraine. The study also indicated that there may be more than one X chromosomal gene involved and implicated a gene involved in iron regulation in the brain.
All females have two X chromosomes ...
Greening operating rooms benefit the bottom line and the environment
2012-06-05
Efforts to "green" operating rooms can result in cost savings for hospitals and reduce the environmental impact without compromising patient care, argues an analysis published in CMAJ (Canadian Medical Association Journal).
"The operating room is a disproportionate contributor to health care waste and represents a high-yield target for change," writes Dr. Yoan Kagoma, Schulich School of Medicine & Dentistry, Western University, London, Ontario, with coauthors.
Operating rooms produce approximately 20%-33% of all waste in hospitals, and much of this waste is subjected ...
Acetaminophen overdoses in children can be life-threatening but are avoidable
2012-06-05
Acetaminophen, a widely available over-the-counter medication, can cause liver toxicity in children if doses are exceeded, and more public education is needed to warn of potential adverse effects, states an article published in CMAJ (Canadian Medical Association Journal).
"Acetaminophen overdose is a major cause of acute liver failure and is the most common identifiable cause of acute liver failure in children," writes Dr. Rod Lim, Department of Pediatrics, Children's Hospital, London Health Sciences Centre, London, Ontario, with coauthors. "Repeated supratherapeutic ...
Canada should ban off-label antibiotic use in agriculture
2012-06-05
Canada should ban off-label use of antibiotics in farm animals because it contributes significantly to antibiotic resistance in humans, states an editorial in CMAJ (Canadian Medical Association Journal).
Off-label use means using antibiotics for purposes other than those indicated on the label.
"Of greatest concern is the promotion of resistance to antibiotics that may currently represent the last resort for treating some highly resistant infections in humans," writes Barbara Sibbald, Deputy Editor, CMAJ.
Other countries and regions are far ahead of Canada in limiting ...
Food for thought? Study says soy may not help preserve thinking skills in women
2012-06-05
MINNEAPOLIS – Contrary to earlier reports, a new study suggests that soy protein may not preserve overall thinking abilities in women over the age of 45, but may improve memory related to facial recognition. The study is published in the June 5, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology.
"Soy is a staple of many traditional Asian diets and has been thought possibly to improve cognition in postmenopausal women," said study author Victor W. Henderson, MD, MS, with Stanford University in Palo Alto, Calif., and a Fellow with ...
How infectious disease may have shaped human origins
2012-06-05
Roughly 100,000 years ago, human evolution reached a mysterious bottleneck: Our ancestors had been reduced to perhaps five to ten thousand individuals living in Africa. In time, "behaviorally modern" humans would emerge from this population, expanding dramatically in both number and range, and replacing all other co-existing evolutionary cousins, such as the Neanderthals.
The cause of the bottleneck remains unsolved, with proposed answers ranging from gene mutations to cultural developments like language to climate-altering events, among them a massive volcanic eruption. ...
Scientists identify mechanism for regulating plant oil production
2012-06-05
UPTON, NY - Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified key elements in the biochemical mechanism plants use to limit the production of fatty acids. The results suggest ways scientists might target those biochemical pathways to increase the production of plant oils as a renewable resource for biofuels and industrial processes.
"Now that we understand how this system operates - how plants 'know' when they've made enough oil and how they slow down production - we can look for ways to break the feedback loop so they keep making ...
Reign of the giant insects ended with the evolution of birds
2012-06-05
SANTA CRUZ, CA--Giant insects ruled the prehistoric skies during periods when Earth's atmosphere was rich in oxygen. Then came the birds. After the evolution of birds about 150 million years ago, insects got smaller despite rising oxygen levels, according to a new study by scientists at the University of California, Santa Cruz.
Insects reached their biggest sizes about 300 million years ago during the late Carboniferous and early Permian periods. This was the reign of the predatory griffinflies, giant dragonfly-like insects with wingspans of up to 28 inches (70 centimeters). ...